Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-1000
Dr. Ignatz-hoover is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University School of MedicineClass of 2018
Certifications & Licensure
OH State Medical License 2018 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Serological pseudoprogression of multiple myeloma after treatment with teclistamab.Michael Daunov, Ibrahim Alagha, Arash Rashidi, Ok-Kyong Chaekal, Koen van Besien
Leukemia & Lymphoma. 2026-04-01 - Engineering TCR-directed T-cells for the treatment of multiple myeloma.Nida Mubin, James J Ignatz-Hoover, James J Driscoll
Frontiers in Immunology. 2026-01-01 - 3 citationsMelphalan 140 mg/mis Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity.Jeries Kort, Nikolas Naleid, Frank Oley, James Ignatz-Hoover, Seunghee Margevicius
Clinical Lymphoma, Myeloma & Leukemia. 2025-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
